Non-invasive Phrenic Nerve Stimulation in ARDS Patient

August 25, 2024 updated by: Ling Liu, Southeast University, China

Non-invasive Phrenic Nerve Stimulation in ARDS Patients - a Feasibility Study

Reduced diaphragmatic activity during mechanical ventilation can lead to diaphragmatic disuse atrophy, atelectasis, increased lung stress and strain, and hemodynamic impairment. This, in turn, may prolong the duration of mechanical ventilation, make weaning more difficult, and even increase mortality. Synchronizing phrenic nerve stimulation to promote diaphragmatic activity may prevent ventilator-induced lung injury and ventilator-induced diaphragm dysfunction, thereby improving patient outcomes. Surgically implanted phrenic nerve stimulation has been used in certain neurological disorders, but the effects of percutaneous non-invasive synchronized phrenic nerve stimulation in patients with ARDS undergoing mechanical ventilation remain unclear and require further investigation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Mechanical ventilation is an important treatment for patients with acute hypoxemic respiratory failure (AHRF). However, reduced diaphragmatic activity during mechanical ventilation can lead to diaphragmatic disuse atrophy, atelectasis, increased lung stress and strain, and hemodynamic impairment. This, in turn, may prolong the duration of mechanical ventilation, make weaning more difficult, and even increase mortality in these patients. In patients with AHRF undergoing mechanical ventilation, maintaining moderate spontaneous breathing under lung and diaphragm protective ventilation remains challenging. Synchronizing phrenic nerve stimulation to promote diaphragmatic activity may prevent ventilator-induced lung injury (VILI) and ventilator-induced diaphragm dysfunction (VIDD), thereby improving patient outcomes. Surgically implanted phrenic nerve stimulation has been used in certain neurological disorders, but the effects of percutaneous non-invasive synchronized phrenic nerve stimulation in patients with acute respiratory distress syndrome (ARDS) undergoing mechanical ventilation remain unclear and require further investigation.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China, 210009
        • Recruiting
        • Zhongda Hospital, School of Medicine, Southeast University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adult ARDS patients undergoing controlled mechanical ventilation
  2. The duration of endotracheal intubation < 48 hrs

Exclusion Criteria:

  1. Neurological condition affecting motor neuron or muscle (e.g. ALS)
  2. Paralysis of the phrenic nerve
  3. Proven or suspected spinal cord injury
  4. Conditions that limit diaphragm movement
  5. Patients with Implanted cardiac support systems (pacemaker, implanted defibrillator)
  6. Patients with implanted medical pumps
  7. Pregnancy
  8. Patients with skin lesions, infections or strictures in throat/neck area
  9. Patients with metallic implants
  10. Refusal to sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PNS group
Electrical stimulation of the phrenic nerve in ARDS patients.
non-invasive phrenic nerve stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of enough Tidal volume
Time Frame: Procedure (from enrollment to extubation)
Percentage of stimulated breaths above the cut-off target tidal volume (3-6 ml/kg ideal body weigh) out of the total number of stimulated breaths
Procedure (from enrollment to extubation)
The speed of successful non-invasive electrical stimulation deployment
Time Frame: Procedure (from enrollment to extubation)
Time between first successful electrical phrenic stimulation and identification of the optimal stimulation locus in seconds
Procedure (from enrollment to extubation)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Driving pressure
Time Frame: Procedure (from enrollment to extubation)
driving pressure was measured in the volume-controlled mode and calculated as the difference between plateau pressure and positive end-expiratory pressure
Procedure (from enrollment to extubation)
Diaphragm thickening fraction
Time Frame: up to 28 days
Diaphragm thickening fraction measured with ultrasound of the diaphragm.
up to 28 days
Diaphragm excursion
Time Frame: up to 28 days
Diaphragm excursion measured with ultrasound of the diaphragm.
up to 28 days
Maximal inspiratory pressure (MIP)
Time Frame: Procedure (from enrollment to extubation)
MIP is measured by the mechanical ventilator during electromagnetic phrenic nerve stimulation.
Procedure (from enrollment to extubation)
ventilation distribution
Time Frame: Procedure (from enrollment to extubation)
ventilation distribution was measured by EIT
Procedure (from enrollment to extubation)
Respiratory system compliance
Time Frame: Procedure (from enrollment to extubation)
Respiratory system compliance is calculated as the ratio of tidal volume to the difference between plateau pressure and positive end-expiratory pressure.
Procedure (from enrollment to extubation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ling liu, phD, Zhongda Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2024

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

January 30, 2025

Study Registration Dates

First Submitted

August 14, 2024

First Submitted That Met QC Criteria

August 25, 2024

First Posted (Actual)

August 27, 2024

Study Record Updates

Last Update Posted (Actual)

August 27, 2024

Last Update Submitted That Met QC Criteria

August 25, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilator-Induced Lung Injury

Clinical Trials on PNS group

Subscribe